Executive Director, Asset Team Lead
Recursion· Development
Remotefull-timePosted 4w ago
About the role
Senior leadership role responsible for defining asset strategy and translating computational/AI insights into strategic asset advantages across oncology and immunology/inflammation programs. Partners across clinical, discovery, ClinTech, platform, and BD to optimize asset positioning, drive portfolio decisions, and deliver transformative medicines.
Responsibilities
- Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation — integrating competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation to sharpen go/no-go and prioritization decisions across the portfolio
- Translate Recursion OS and ClinTech insights into strategic asset advantages, ensuring proprietary data and computational insights are maximally enabling for advancement of the drug discovery and development portfolio
- Develop and pressure-test the competitive narrative for each oncology and I&I portfolio asset, building the evidence base for leadership decisions, partnering discussions and investor communications
- Partner with functional line leaders across clinical development, BD, finance and platform teams to ensure resource allocation reflects strategic conviction and supports the most impactful programs and workstreams
- Propagate the Recursion mindset of radically changing lives by continuously raising the bar on how assets are advanced, differentiated, and delivered to patients with significant unmet need
Qualifications
- A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development required
- 10+ years of biotech/pharma experience with a proven track record of asset-level strategic leadership, advancing programs through clinical stage-gates with demonstrable impact on portfolio value
- Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation required, expertise in rare disease a bonus
- Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
- Proven ability to build and articulate the strategic and competitive case for clinical assets – integrating mechanistic differentiation, competitive dynamics, regulatory and market considerations
- Strong financial acumen; able to engage credibly on cross-functional resourcing, asset valuation, and portfolio trade-offs
- Exceptional executive presence – able to synthesize complexity into clear, conviction-led recommendations and present with confidence to senior leadership and external partners
Skills
Required:Asset strategy developmentStrategic storytelling and competitive narrativeComputational/data-driven decision supportCross-functional leadershipFinancial acumen in portfolio management
Benefits
- annual bonus
- equity compensation
- comprehensive benefits package
Last updated Sep 23, 2026. Interested? Apply on the company site.
About Recursion
Pioneering AI Drug Discovery | Recursion
Decoding biology to radically improve lives.
AIdrug discoverybiotechpharmaRecursion OSdatamodelscompute
More open roles at Recursion
- Executive Director, Chemical Biology5d agoHybrid (Salt Lake City, UT) · Chemistry
- Staff Engineer, Identity & Access Management (IAM)1w agoHybrid (Remote United States; Salt Lake City, Utah) · IT
- Scientist, Assay Development (Contractor)2w agoSalt Lake City, UT · Biology
- Executive Director, Clinical Pharmacology/Pharmacometrics3w agoHybrid (Remote United States) · Development
- Executive Director, Clinical Pharmacology/Pharmacometrics3w agoRemote · Development